Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells

被引:110
作者
Leen, AM
Sili, U
Vanin, EF
Jewell, AM
Xie, WD
Vignali, D
Piedra, PA
Brenner, MK
Rooney, CM
机构
[1] Baylor Coll Med, Dept Pediat, Ctr Cell & Gene Therapy, Dept Med, Houston, TX USA
[2] Baylor Coll Med, Dept Mol Virol & Microbiol, Ctr Cell & Gene Therapy, Houston, TX USA
[3] Texas Childrens Hosp, Houston, TX 77030 USA
[4] Methodist Hosp, Houston, TX 77030 USA
[5] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN USA
关键词
D O I
10.1182/blood-2004-02-0646
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adenoviruses often cause lethal infections in immunocompromised individuals. Adoptive transfer of immune T cells offers a therapeutic option, but this strategy has been hindered by the paucity of information on molecular targets of cellular immunity and by the immunologic heterogeneity of the 51 human adenoviruses, which are grouped from A to F on the basis of genome size, composition, homology, and organization. Clonal analysis of the adenovirus-specific cytotoxic T lymphocyte (CTL) responses of seropositive individuals identified 5 novel CD8(+) T-cell epitopes, all located in conserved regions of the capsid protein hexon. Reactive T cells were cross-reactive between 2 to 4 groups, while no T cells specific for a single subgroup were detected. Thus, by exploiting these peptide targets, it is possible to prepare a T-cell population capable of reacting with most adenoviruses that cause disease in immunocompromised patients. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:2432 / 2440
页数:9
相关论文
共 50 条
  • [1] [Anonymous], 2000, The HLA Facts Book
  • [2] Incidence and outcome of Adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab
    Avivi, I
    Chakrabarti, S
    Milligan, DW
    Waldmann, H
    Hale, G
    Osman, H
    Ward, KN
    Fegan, CD
    Yong, K
    Goldstone, AH
    Limb, DC
    MacKinnon, S
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (03) : 186 - 194
  • [3] Human CD8+ T cell responses to EBV EBNA1:: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing
    Blake, N
    Lee, S
    Redchenko, I
    Thomas, W
    Steven, N
    Leese, A
    Steigerwald-Mullen, P
    Kurilla, MG
    Frappier, L
    Rickinson, A
    [J]. IMMUNITY, 1997, 7 (06) : 791 - 802
  • [4] The importance of exogenous antigen in priming the human CD8+ T cell response:: Lessons from the EBV nuclear antigen EBNA1
    Blake, N
    Haigh, T
    Shaka'a, G
    Croom-Carter, D
    Rickinson, A
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (12) : 7078 - 7087
  • [5] Bordigoni Pierre, 2001, Clinical Infectious Diseases, V32, P1290, DOI 10.1086/319984
  • [6] T cell affinity maturation by selective expansion during infection
    Busch, DH
    Pamer, EG
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (04) : 701 - 709
  • [7] Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery
    Chakrabarti, S
    Mautner, V
    Osman, H
    Collingham, KE
    Fegan, CD
    Klapper, PE
    Moss, PAH
    Milligan, DW
    [J]. BLOOD, 2002, 100 (05) : 1619 - 1627
  • [8] Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy
    Chakrabarti, S
    Collingham, KE
    Fegan, CD
    Milligan, DW
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 (11) : 1209 - 1211
  • [9] HIGH-TITER PACKAGING CELLS PRODUCING RECOMBINANT RETROVIRUSES RESISTANT TO HUMAN SERUM
    COSSET, FL
    TAKEUCHI, Y
    BATTINI, JL
    WEISS, RA
    COLLINS, MKL
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (12) : 7430 - 7436
  • [10] Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues
    CrawfordMiksza, L
    Schnurr, DP
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (03) : 1836 - 1844